Study on the Supportive Effect of Personalized Nostril Retainer in Unilateral Cleft Lip Surgery

September 29, 2026 updated by: Dinh Dieu Hong, Hanoi Medical University

The objective of this clinical trial is to evaluate the supportive effectiveness of a customized nostril retainer in unilateral cleft lip repair at several hospitals in Hanoi. The main question that this trial aims to answer is: Does a customized nostril retainer help improve the aesthetic reconstruction of the nose in children following unilateral cleft lip repair?

The researchers will compare the use and non-use of a customized nostril retainer to determine whether the retainer is effective in supporting the aesthetic reconstruction of the nose.

Participants will be divided into two groups (the intervention group and the control group):

Study population: Patients younger than 18 months with unilateral cleft lip who undergo primary lip and nasal repair.

Intervention group: Participants who use a customized nostril retainer after unilateral cleft lip repair.

Control group: Participants who do not use a customized nostril retainer after unilateral cleft lip repair.

Follow-up: Participants will return for follow-up visits at 1 week, 3 months, and 6 months after surgery.

Outcome assessment: Nasal aesthetics will be evaluated at each follow-up visit, along with the convenience and ease of use of the retainer, assessed through interviews with caregivers.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 months to 1 year (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients younger than 18 months with unilateral cleft lip who undergo primary lip and nasal repair.
  • No local infection or inflammation.
  • No associated congenital anomalies other than cleft lip and/or cleft palate.

Exclusion Criteria:

  • Participants who do not meet any one of the inclusion criteria.
  • Patients who are unable to attend follow-up visits.
  • Families or legal guardians who refuse to participate in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention arm: customized nostril retainer

Participants who use a customized nostril retainer after unilateral cleft lip repair.

Participants will undergo unilateral cleft lip repair and will then be assigned to either receive or not receive a customized nostril retainer.

No Intervention: Control arm - Non-customized nostril retainer

Participants who do not use a customized nostril retainer after unilateral cleft lip repair

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-intervention nasal symmetry
Time Frame: at 1 week, 3 months, and 6 months postoperatively

Columellar deviation: This measure is assessed by the angle formed between the tangent line passing through the nasal base and the line passing through the midpoint of the columella. The value ranges from 0° to 90°, with a larger angle indicating a better outcome.

Degree of alar collapse on the affected side compared with the unaffected side: This measure is assessed as the ratio of the alar height on the affected side to the alar height on the unaffected side. The value ranges from 0% to 100%, with a higher ratio indicating a better outcome.

at 1 week, 3 months, and 6 months postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
convenience and ease of use of the retainer
Time Frame: at 1 week, 3 months, and 6 months postoperatively

Adverse effects: This variable determines the presence or absence of adverse effects associated with the use of the device (e.g., whether the child is irritable or fussy, and whether there is redness or an inflammatory reaction at the device-skin contact area).

Convenience and satisfaction: Scores are rated on a 1-5 scale, corresponding to very dissatisfied - dissatisfied - neutral - satisfied - very satisfied, respectively. A higher score indicates greater convenience and satisfaction.

at 1 week, 3 months, and 6 months postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

May 31, 2027

Study Completion (Estimated)

July 31, 2027

Study Registration Dates

First Submitted

September 17, 2026

First Submitted That Met QC Criteria

September 29, 2026

First Posted (Actual)

September 30, 2026

Study Record Updates

Last Update Posted (Actual)

September 30, 2026

Last Update Submitted That Met QC Criteria

September 29, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 972050.1789

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe